Terms: = Liver cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292
139 results:
1. Higher risk of hepatotoxicity associated with cabozantinib in cancer patients.
Wang Z; Jiang L; Lv X; Yin H; Wang Z; Li W; Liu Y
Crit Rev Oncol Hematol; 2024 Apr; 196():104298. PubMed ID: 38364886
[TBL] [Abstract] [Full Text] [Related]
2. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance.
Choi HH; Kim S; Shum DJ; Huang CY; Shui A; Fox RK; Khalili M
Radiol Imaging Cancer; 2024 Jan; 6(1):e230118. PubMed ID: 38214600
[TBL] [Abstract] [Full Text] [Related]
3. Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis.
Tian S; Hu Y; Zhang M; Wang K; Guo G; Li B; Shang Y; Han Y
Arthritis Res Ther; 2023 Oct; 25(1):186. PubMed ID: 37784152
[TBL] [Abstract] [Full Text] [Related]
4. Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma.
Zhao YM; Xie SS; Wang J; Zhang YM; Li WC; Ye ZX; Shen W
BMC Med Imaging; 2023 Sep; 23(1):138. PubMed ID: 37737166
[TBL] [Abstract] [Full Text] [Related]
5. A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Huang J; Cui W; Xie X; Lin K; Jin D; Xie X; Zhuang B
Int J Hyperthermia; 2023; 40(1):2256498. PubMed ID: 37733400
[TBL] [Abstract] [Full Text] [Related]
6. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma.
Giaccherini M; Gori L; Gentiluomo M; Farinella R; Cervena K; Skieceviciene J; Dijk F; Capurso G; Vezakis A; Archibugi L; Chammas R; Hussein T; Tavano F; Hegyi P; Lovecek M; Izbicki JR; Brenner H; Mohelnikova-Duchonova B; Dell'Anna G; Kupcinskas J; Ermini S; Aoki MN; Neoptolemos JP; Gazouli M; Pasquali C; Pezzilli R; Talar-Wojnarowska R; Oliverius M; Al-Saeedi M; Lucchesi M; Furbetta N; Carrara S; van Eijck CHJ; Maleckas A; Milanetto AC; Lawlor RT; Schöttker B; Boggi U; Morelli L; Ginocchi L; Ponz de Leon Pisani R; Sperti C; Zerbi A; Arcidiacono PG; Uzunoglu FG; Bunduc S; Holleczek B; Gioffreda D; Małecka-Wojciesko E; Kiudelis M; Szentesi A; van Laarhoven HWM; Soucek P; Götz M; Erőss B; Cavestro GM; Basso D; Perri F; Landi S; Canzian F; Campa D
Carcinogenesis; 2023 Dec; 44(8-9):642-649. PubMed ID: 37670727
[TBL] [Abstract] [Full Text] [Related]
7. METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.
Liu R; Yin G; Tuo H; Guo Y; Zhu Y; Zhang L; Yang W; Liu Q; Wang Y
Biol Direct; 2023 Sep; 18(1):53. PubMed ID: 37658413
[TBL] [Abstract] [Full Text] [Related]
8. Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study.
Li L; Yao J; Yan X; Qi X; Liang P; Han Z; Liu F; Cheng Z; Luo Y; Zheng R; Cheng W; Wei Q; Yu S; Yu J; Yu X
Int J Hyperthermia; 2023; 40(1):2248425. PubMed ID: 37607775
[TBL] [Abstract] [Full Text] [Related]
9. External validation of the Japanese difficulty score for laparoscopic hepatectomy in patients undergoing robotic-assisted hepatectomy.
Ricker AB; Davis JM; Motz BM; Watson M; Beckman M; Driedger M; Martinie JB; Vrochides D
Surg Endosc; 2023 Sep; 37(9):7288-7294. PubMed ID: 37558825
[TBL] [Abstract] [Full Text] [Related]
10. A multicentre, multinational study of clinical characteristics and prognosis of hepatocellular carcinoma.
Dirican A; Uncu D; Sekacheva M; Artaç M; Aladashvil A; Erdogan A; Kaplan M; Alacacıoğlu A; Boukovinas I; Turhal N
East Mediterr Health J; 2023 Jun; 29(6):462-473. PubMed ID: 37551758
[TBL] [Abstract] [Full Text] [Related]
11. Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro.
Kersten V; Seitz T; Sommer J; Thasler WE; Bosserhoff A; Hellerbrand C
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446238
[TBL] [Abstract] [Full Text] [Related]
12. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
[No Abstract] [Full Text] [Related]
13. Nodules Identified on Surveillance Ultrasound for HCC: CEUS or MRI as the Initial Test?
Hu J; Burrowes DP; Caine BA; Gibson N; Bhayana D; Medellin A; Burak KW; Wilson SR
J Ultrasound Med; 2023 Jun; 42(6):1181-1190. PubMed ID: 36807925
[TBL] [Abstract] [Full Text] [Related]
14. NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma.
Li Z; You C; Huang J; Zhang M
Med Sci Monit; 2023 Jan; 29():e938410. PubMed ID: 36680333
[TBL] [Abstract] [Full Text] [Related]
15. Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
Sohn W; Kang D; Kang M; Guallar E; Cho J; Paik YH
Clin Mol Hepatol; 2022 Oct; 28(4):851-863. PubMed ID: 36263667
[TBL] [Abstract] [Full Text] [Related]
16. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract] [Full Text] [Related]
17. Curative-intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging-guided thermal ablation and surgery.
Karam E; Tabutin M; Mastier C; Crignis L; Peyrat P; Martin V; Badon F; Muller X; Meeus P; Rivoire M; Dupré A
J Surg Oncol; 2023 Jan; 127(1):183-191. PubMed ID: 36169242
[TBL] [Abstract] [Full Text] [Related]
18. ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis.
Jiang K; Chen H; Ding K
Clin Sci (Lond); 2022 Sep; 136(18):1367-1370. PubMed ID: 36156125
[TBL] [Abstract] [Full Text] [Related]
19. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.
Xiao Y; Zheng X; Zhou C; Huang P; Wu F; Yang C; Zeng M
Eur Radiol; 2023 Feb; 33(2):1412-1421. PubMed ID: 36112193
[TBL] [Abstract] [Full Text] [Related]
20. Current cancer burden in China: epidemiology, etiology, and prevention.
Maomao C; He L; Dianqin S; Siyi H; Xinxin Y; Fan Y; Shaoli Z; Changfa X; Lin L; Ji P; Wanqing C
Cancer Biol Med; 2022 Aug; 19(8):1121-38. PubMed ID: 36069534
[TBL] [Abstract] [Full Text] [Related]
[Next]
